Latest News

July 28, 2016, at 7 pm. Speaker: Dr. Shahrooz Eshaghian  Subject: Chemotherapy for Prostate Cancer: Earlier Better? Facts & Myths of a Systemic Approach in the Treatment of High Risk or Metastatic Prostate Cancer. Speaker: Dr. Bob Leibowitz  Subject: Dr. Bob’s …

Alternate

serving patients globally

Click here to see how far our patients travel to see us. Explore our US map. Explore our International map.

 

DrEshaghian-DrBob-SmallWELCOME TO COMPASSIONATE ONCOLOGY

Dr. Bob has been treating cancer patients since 1970.

In 1967, when Dr. Bob was a 2nd year medical student, he attended his first “Tumor Board”.  Dr. Bob heard medical histories presented and recommendations for treatment of these cancer patients discussed by various types of cancer specialists.  Dr. Bob discovered this is what he wanted to do – to treat patients with cancer.

For the past 40 plus years, Dr. Bob has contributed to the explosion in knowledge and treatment options for patients with cancer.

Beginning in 1991, Dr. Bob began to sub-specialize in prostate cancer and since 1997, almost all of our new patients have prostate cancer.

Dr. Bob takes extreme pride that our Compassionate Oncology Medical Group has been able to make major contributions to the treatment of men with every stage of prostate cancer.

For men with low or intermediate risk prostate cancer (PC), Dr. Bob conceived, named, pioneered and was the first to publish the results of his unique medical protocol for the treatment of these stages of PC, which he named Triple Hormone Blockade® (also known as Triple Androgen Blockade®) followed by Finasteride Maintenance® Therapy. In 2003, the U.S. Trademark Office issued trademark registrations for Triple Hormone Blockade®, Triple Androgen Blockade® and Finasteride Maintenance® as brand names for this non-invasive but extremely effective treatment protocol.

Later, Dr. Bob conceived, named and pioneered the use of weekly low dose Taxotere/Emcyt/Carboplatinum chemotherapy 3 weeks on; 1 week off.  Additional major treatment contributions by Dr. Bob and Compassionate Oncology Medical Group have included Dr. Bob’s Prostate Cancer Anti-angiogenic Cocktail, Dr. Bob’s Three Pronged Approach for treating high risk or advanced disease, and Dr. Bob’s High-Dose Testosterone Replacement Therapy approach.  These and Dr. Bob’s other contributions are described in his various recorded lectures (available for order by calling our office at 310-229-3555) and many are also described in his various papers that can be downloaded for free under Publications on this website.

Read Dr. Eshaghian’s Article in PAACT

ON THE HORIZON – INDIVIDUALIZED BIOMARKER DRIVEN THERAPY IN CASTRATE RESISTANT PROSTATE CANCER (CRPC) –

Click Here to Read the Full article

COMG Doctors Speaking at The Prostate Forum

July 28, 2016, at 7 pm.

Speaker: Dr. Shahrooz Eshaghian

 Subject: Chemotherapy for Prostate Cancer: Earlier Better? Facts & Myths of a Systemic Approach in the Treatment of High Risk or Metastatic Prostate Cancer.

Speaker: Dr. Bob Leibowitz

 Subject: Dr. Bob’s High Dose Testosterone Replacement Therapy Protocol for Successfully

Dr. Eshaghian will update us on what is fact and what is fiction when treating high risk and/or metastatic PCa. Dr. Bob will update us on ‘Challenging Prostate Cancer Treatment Biases; Is Nothing Sacred?”

Dr. Shahrooz Eshaghian is a Diplomate of the American Board of Internal Medicine with subspecialty in Hematology & Oncology. After graduating from UCLA, he received his doctorate of medicine from Albert Einstein College of Medicine. He completed his internship & residency at Cedars Sinai Medical Center and his fellowship at UCLA. He is an active attending physician at Cedars Sinai Medical Center and clinical instructor at UCLA. He strives to provide state-of-the-art, personalized and compassionate care to patients around the world and in the community at Compassionate Oncology Medical Group—internationally recognized for the treatment of prostate cancer—along with Dr. Robert Leibowitz.

DVD #11 is Now Available Online!

Watch Dr. Bob & Dr. Eshaghian’s latest lecture, titled “Our Three-Pronged Approach Protocol for treatment of high-risk metastatic and/or recurrent prostate cancer and results from hundreds of PC patients utilizing High-Dose Testosterone Replacement Therapy”.  Watch online by clicking here!